GLS and osteosarcoma: Glutaminase (marker of glutaminolysis) was highly expressed in 53.6% of the cases, with a median H-score of 102, suggesting that glutamine may be used as an alternative bioenergetic substrate in osteosarcoma tumorigenesis (Figure 3).